<DOC>
	<DOCNO>NCT02317575</DOCNO>
	<brief_summary>This study evaluate four test formulation glucose lower drug ( LY900014 ) administer injection skin abdomen . The study conduct healthy people investigate human body handle LY900014 effect LY900014 blood sugar level . Side effect tolerability document . The study conduct two part ( Part A Part B ) achieve objective . Each part study last 11 12 week , include screen follow . Screening require within 28 day prior enter either study Part A Part B .</brief_summary>
	<brief_title>A Study LY900014 Formulations Healthy Participants</brief_title>
	<detailed_description />
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Lispro</mesh_term>
	<criteria>Overtly healthy male female ( pregnant agreeable take birth control measure one month study completion ) Have body mass index ( BMI ) 18.5 30 kilogram per square meter ( kg/m^2 ) , inclusive , screen Have normal blood pressure , pulse rate , electrocardiogram ( ECG ) , blood urine laboratory test result acceptable study Are nonsmoker , smoke least 2 month prior enter study , agree smoke ( cigar , cigarette , pipe ) use smokeless tobacco duration study Are currently participate complete clinical trial within last 30 day clinical trial type medical research judge incompatible study Have previously participate withdrawn study Have use health problem laboratory test result ECG reading , opinion doctor , could make unsafe participate , could interfere understand result study</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>